KingSung Medical Group whose total registered capital is 80 million RMB was founded in 2006. The headquarters is located in HongKong, and marketing center is located in Beijing. It has three subsidiaries: Yi Lin Ke Chuang Medical Technology（Beijing）Co.,Ltd, Hua Rong Ke Chuang Biotechnology (Tianjin) Co., Ltd and Chuang Mei De Medical Device (Tianjin) Co., Ltd. It is a medical group integrated with production, development, and sales together, focusing on medical healthcare and providing world-leading medical technology with exclusive value and service and its core products have self-independent intellectual property rights.

        KingSung Medical Group has three business divisions: Surgical products are microvascular anastomotic device and neurotube from US, and micro instruments from S&T, Switzerland; orthopedic products are traumatic orthopedic products from TriMed, US, and orthopedic products from Chuang Mei De Medical Device (TianJin)Co., Ltd，a sino-us joint venture; aesthetic products are mammary implants from GCA French, hyaluronic acid from ADODERM, Germany. KingSung Medical Group provides the advanced products, technology and professional service internationally. Its marketing team spread all over the country. It has direct sales team in 10 cities, such as Beijing, Shanghai, Guangzhou, Ningbo, Wuxi, Nantong, Jinan, Qingdao, Weifang, and Shenyang. Its channel marketing sales and agents in every province can supply professional service for clinic. 

        In the past decade, KingSung Medical Group has not only promoted the international leading medical technology to the clinic in an orderly way, but also infused new technology and energy into the development of China healthcare. It also attaches more importance to surgeon education and training. KingSung has long-term cooperation with the Chinese Society of Microsurgery, and the Chinese Society of Oral and Maxillofacial Surgery, and has organized various forms of national academic exchanges, such as the public welfare academic activity “KingSung Cup" national excellent case competition, new technology excellent video competition for the vascular anastomosis, as well as support for the national training centers  and provincial academic conferences which established an excellent brand image in the field of microsurgery. In the future, KingSung will continue to extend our academic support philosophy to orthopedic and aesthetic markets for the new technology’s education and training, and to contribute to help China healthcare in the global market. All staff of KingSung medical group will strive for the realization of "international medical enterprise with brand value" with full enthusiasm and professional ability.